Other
Lake Washington Vascular
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
N/A
2(100.0%)
2Total
N/A(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT04146168Unknown
Lake Washington Vascular VenaSeal™ Post-Market Evaluation
Role: lead
NCT04006184Completed
Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation
Role: lead
NCT02585726Not ApplicableCompleted
Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES)
Role: lead
NCT01332838Not ApplicableUnknown
A Comparison of Specialized Versus Standard Compression After Saphenous Ablation
Role: collaborator
All 4 trials loaded